Zymeworks Revenue 2016-2022 | ZYME
Zymeworks revenue from 2016 to 2022. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Zymeworks Annual Revenue
(Millions of US $) |
| 2021 |
$27 |
| 2020 |
$39 |
| 2019 |
$30 |
| 2018 |
$53 |
| 2017 |
$52 |
| 2016 |
$11 |
| 2015 |
$10 |
Zymeworks Quarterly Revenue
(Millions of US $) |
| 2022-06-30 |
$5 |
| 2022-03-31 |
$2 |
| 2021-12-31 |
$20 |
| 2021-09-30 |
$4 |
| 2021-06-30 |
$2 |
| 2021-03-31 |
$1 |
| 2020-12-31 |
$16 |
| 2020-09-30 |
$3 |
| 2020-06-30 |
$12 |
| 2020-03-31 |
$8 |
| 2019-12-31 |
$2 |
| 2019-09-30 |
$8 |
| 2019-06-30 |
$8 |
| 2019-03-31 |
$12 |
| 2018-12-31 |
$29 |
| 2018-09-30 |
$2 |
| 2018-06-30 |
$22 |
| 2018-03-31 |
$0 |
| 2017-12-31 |
$50 |
| 2017-09-30 |
$0 |
| 2017-06-30 |
$1 |
| 2017-03-31 |
$0 |
| 2016-12-31 |
$2 |
| 2016-09-30 |
$2 |
| 2016-06-30 |
$6 |
| 2016-03-31 |
$0 |
| 2015-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.525B |
$0.412B |
|
Zymeworks Inc. is a clinical-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of bio-therapeutics for the treatment of cancer in Canada. The companys lead product candidate includes ZW25 and ZW33 which are in clinical trial stage. Zymeworks Inc. is headquartered in Vancouver, Canada.
|
